Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain

Steven A. Rubin, Mikhail Pletnikov, Kathryn M. Carbone

Research output: Contribution to journalArticle

Abstract

Prior to the adoption of widespread vaccination programs, mumps virus was the leading cause of virus-induced central nervous system (CNS) disease. Mumps virus-associated CNS complications in vaccinees continue to be reported; outside the United States, some of these complications have been attributed to vaccination with insufficiently attenuated neurovirulent vaccine strains. The development of potentially neurovirulent, live, attenuated mumps virus vaccines stems largely from the lack of an animal model that can reliably predict the neurovirulence of mumps virus vaccine candidates in humans. The lack of an effective safety test with which to measure mumps virus neurovirulence has also hindered analysis of the neuropathogenesis of mumps virus infection and the identification of molecular determinants of neurovirulence. In this report we show, for the first time, that mumps virus infection of the neonatal rat leads to developmental abnormalities in the cerebellum due to cerebellar granule cell migration defects. The incidence of the cerebellar abnormalities and other neuropathological and clinical outcomes of mumps virus infection of the neonatal rat brain demonstrated the ability of this model to distinguish neurovirulent (Kilham) from nonneurovirulent (Jeryl Lynn) mumps virus strains. Thus, this neonatal rat model may prove useful in evaluating the neurovirulence potential of new live, attenuated vaccine strains and may also be of value in elucidating the molecular basis of mumps virus neurovirulence.

Original languageEnglish (US)
Pages (from-to)8037-8042
Number of pages6
JournalJournal of Virology
Volume72
Issue number10
StatePublished - Oct 1998

Fingerprint

Mumps virus
Vaccines
vaccines
brain
rats
Brain
Virus Diseases
Mumps Vaccine
Attenuated Vaccines
neonates
live vaccines
Vaccination
animal models
vaccination
infection
central nervous system diseases
Central Nervous System Diseases
abnormal development
cerebellum
Cerebellum

ASJC Scopus subject areas

  • Immunology

Cite this

Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain. / Rubin, Steven A.; Pletnikov, Mikhail; Carbone, Kathryn M.

In: Journal of Virology, Vol. 72, No. 10, 10.1998, p. 8037-8042.

Research output: Contribution to journalArticle

@article{e2e10bb62ba946c6a7344a39c4c5ec27,
title = "Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain",
abstract = "Prior to the adoption of widespread vaccination programs, mumps virus was the leading cause of virus-induced central nervous system (CNS) disease. Mumps virus-associated CNS complications in vaccinees continue to be reported; outside the United States, some of these complications have been attributed to vaccination with insufficiently attenuated neurovirulent vaccine strains. The development of potentially neurovirulent, live, attenuated mumps virus vaccines stems largely from the lack of an animal model that can reliably predict the neurovirulence of mumps virus vaccine candidates in humans. The lack of an effective safety test with which to measure mumps virus neurovirulence has also hindered analysis of the neuropathogenesis of mumps virus infection and the identification of molecular determinants of neurovirulence. In this report we show, for the first time, that mumps virus infection of the neonatal rat leads to developmental abnormalities in the cerebellum due to cerebellar granule cell migration defects. The incidence of the cerebellar abnormalities and other neuropathological and clinical outcomes of mumps virus infection of the neonatal rat brain demonstrated the ability of this model to distinguish neurovirulent (Kilham) from nonneurovirulent (Jeryl Lynn) mumps virus strains. Thus, this neonatal rat model may prove useful in evaluating the neurovirulence potential of new live, attenuated vaccine strains and may also be of value in elucidating the molecular basis of mumps virus neurovirulence.",
author = "Rubin, {Steven A.} and Mikhail Pletnikov and Carbone, {Kathryn M.}",
year = "1998",
month = "10",
language = "English (US)",
volume = "72",
pages = "8037--8042",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain

AU - Rubin, Steven A.

AU - Pletnikov, Mikhail

AU - Carbone, Kathryn M.

PY - 1998/10

Y1 - 1998/10

N2 - Prior to the adoption of widespread vaccination programs, mumps virus was the leading cause of virus-induced central nervous system (CNS) disease. Mumps virus-associated CNS complications in vaccinees continue to be reported; outside the United States, some of these complications have been attributed to vaccination with insufficiently attenuated neurovirulent vaccine strains. The development of potentially neurovirulent, live, attenuated mumps virus vaccines stems largely from the lack of an animal model that can reliably predict the neurovirulence of mumps virus vaccine candidates in humans. The lack of an effective safety test with which to measure mumps virus neurovirulence has also hindered analysis of the neuropathogenesis of mumps virus infection and the identification of molecular determinants of neurovirulence. In this report we show, for the first time, that mumps virus infection of the neonatal rat leads to developmental abnormalities in the cerebellum due to cerebellar granule cell migration defects. The incidence of the cerebellar abnormalities and other neuropathological and clinical outcomes of mumps virus infection of the neonatal rat brain demonstrated the ability of this model to distinguish neurovirulent (Kilham) from nonneurovirulent (Jeryl Lynn) mumps virus strains. Thus, this neonatal rat model may prove useful in evaluating the neurovirulence potential of new live, attenuated vaccine strains and may also be of value in elucidating the molecular basis of mumps virus neurovirulence.

AB - Prior to the adoption of widespread vaccination programs, mumps virus was the leading cause of virus-induced central nervous system (CNS) disease. Mumps virus-associated CNS complications in vaccinees continue to be reported; outside the United States, some of these complications have been attributed to vaccination with insufficiently attenuated neurovirulent vaccine strains. The development of potentially neurovirulent, live, attenuated mumps virus vaccines stems largely from the lack of an animal model that can reliably predict the neurovirulence of mumps virus vaccine candidates in humans. The lack of an effective safety test with which to measure mumps virus neurovirulence has also hindered analysis of the neuropathogenesis of mumps virus infection and the identification of molecular determinants of neurovirulence. In this report we show, for the first time, that mumps virus infection of the neonatal rat leads to developmental abnormalities in the cerebellum due to cerebellar granule cell migration defects. The incidence of the cerebellar abnormalities and other neuropathological and clinical outcomes of mumps virus infection of the neonatal rat brain demonstrated the ability of this model to distinguish neurovirulent (Kilham) from nonneurovirulent (Jeryl Lynn) mumps virus strains. Thus, this neonatal rat model may prove useful in evaluating the neurovirulence potential of new live, attenuated vaccine strains and may also be of value in elucidating the molecular basis of mumps virus neurovirulence.

UR - http://www.scopus.com/inward/record.url?scp=0031717606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031717606&partnerID=8YFLogxK

M3 - Article

C2 - 9733843

AN - SCOPUS:0031717606

VL - 72

SP - 8037

EP - 8042

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 10

ER -